×

Category: Press Releases

Ora Rapamycin Project
Ora Biomedical, in partnership with Rapamycin Longevity Lab, announces the successful funding of the first subproject under its ambitious initiative to conduct a rapid lifespan analysis of 601 mTOR inhibitors in roundworms. With $50,000 secured, Ora Biomedical will now commence the next phase of the first subproject. This will be a high-throughput screening of 301...
Rejuve.ai logo
Longevity research network, Rejuve.AI, today launches Rejuve Longevity, an app that combines AI, cutting-edge research and blockchain technology to widen access to longevity treatments and advice. Rejuve Longevity analyzes users’ demographic, medical, and lifestyle data to give them a biological age estimate, alongside other personalized health insights. At its core, Rejuve Longevity is designed to...
LongX Logo
LongX, an initiative dedicated to providing avenues into the longevity space, announced a call for applications for the 2025 Xplore Program. With its inaugural cohort launching last year, the Xplore Program is a remote fellowship open to early career professionals and students looking for their first steps in longevity biotechnology. The 2nd edition will take...
Environmental exposure
Recent research confirms the relatively minor role that genetics plays in our health, with the ‘exposome’, defined as the totality of exposures individuals experience over their lives affecting their health, responsible for 10 times more variation in mortality risk than genetic predisposition [1]. A paper published in Nature Medicine today, ‘Cities, communities and clinics can...
Longevity Science Summit
The Longevity Science Foundation (LSF) is thrilled to announce that it is organizing the Longevity Science Summit in Miami – the future hub of longevity sciences in the United States. The event will spotlight the latest advancements in healthy human longevity research and unite the local community for an evening of networking, collaboration, and celebration....
Junevity
Junevity, a biotechnology company on a mission to extend lifespan and healthspan by resetting cell damage from age-related diseases, today announced $10 million in seed funding led by Goldcrest Capital and Godfrey Capital. The Junevity RESET platform is based on exclusively licensed research by co-founder Dr. Janine Sengstack at the University of California at San...